Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR.

Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10540-3.

2.

Aging- and oxygen-induced modifications in brain biochemistry and behavior.

Carney JM, Smith CD, Carney AM, Butterfield DA.

Ann N Y Acad Sci. 1994 Nov 17;738:44-53.

PMID:
7832454
3.

Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation.

Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM, et al.

J Neurochem. 1995 Nov;65(5):2146-56.

PMID:
7595501
4.

Protein oxidation in aging brain.

Smith CD, Carney JM, Tatsumo T, Stadtman ER, Floyd RA, Markesbery WR.

Ann N Y Acad Sci. 1992 Nov 21;663:110-9. No abstract available.

PMID:
1362341
5.

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA.

Free Radic Biol Med. 2002 Aug 15;33(4):562-71.

PMID:
12160938
6.

Reductions in brain phosphatidylinositol kinase activities in Alzheimer's disease.

Zubenko GS, Stiffler JS, Hughes HB, Martinez AJ.

Biol Psychiatry. 1999 Mar 15;45(6):731-6.

PMID:
10188002
7.

White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study.

Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J.

Arch Neurol. 2003 Mar;60(3):393-8.

PMID:
12633151
8.

Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction.

Reddy PH, Mani G, Park BS, Jacques J, Murdoch G, Whetsell W Jr, Kaye J, Manczak M.

J Alzheimers Dis. 2005 Apr;7(2):103-17; discussion 173-80.

PMID:
15851848
9.

Patterns of brain activity during a semantic task differentiate normal aging from early Alzheimer's disease.

McGeown WJ, Shanks MF, Forbes-McKay KE, Venneri A.

Psychiatry Res. 2009 Sep 30;173(3):218-27. doi: 10.1016/j.pscychresns.2008.10.005. Epub 2009 Aug 14.

PMID:
19683419
10.

Alterations in tau protein metabolism during normal aging.

Mukaetova-Ladinska EB, Harrington CR, Roth M, Wischik CM.

Dementia. 1996 Mar-Apr;7(2):95-103.

PMID:
8866683
12.

Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis.

Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA.

J Neurosci. 1995 Sep;15(9):6213-21.

13.

Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease.

Korolainen MA, Nyman TA, Nyyssönen P, Hartikainen ES, Pirttilä T.

Clin Chem. 2007 Apr;53(4):657-65. Epub 2007 Feb 8.

14.

Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease.

Mastrogiacoma F, Lindsay JG, Bettendorff L, Rice J, Kish SJ.

Ann Neurol. 1996 May;39(5):592-8.

PMID:
8619544
15.

Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.

Tannenberg RK, Scott HL, Tannenberg AE, Dodd PR.

Neurochem Int. 2006 Dec;49(7):631-9. Epub 2006 Jun 30.

PMID:
16814428
16.

Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-butyl-alpha-phenylnitrone and vitamin E.

Butterfield DA, Koppal T, Howard B, Subramaniam R, Hall N, Hensley K, Yatin S, Allen K, Aksenov M, Aksenova M, Carney J.

Ann N Y Acad Sci. 1998 Nov 20;854:448-62. Review.

PMID:
9928452
17.

Reduced phosphatidylinositol kinase activity in Alzheimer's disease: effects of age and onset.

Jolles J, Bothmer J, Markerink M, Ravid R.

Dementia. 1993 Mar-Apr;4(2):81-6.

PMID:
8395284
18.

Phosphoprotein phosphatase activities in Alzheimer disease brain.

Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K.

J Neurochem. 1993 Sep;61(3):921-7.

PMID:
8395566
19.

Ouabain binding in the human brain. Effects of Alzheimer's disease and aging.

Harik SI, Mitchell MJ, Kalaria RN.

Arch Neurol. 1989 Sep;46(9):951-4.

PMID:
2549926

Supplemental Content

Support Center